Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Staphylococcal Infections | 3 | 2018 | 1099 | 1.06 | Why? |
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2018 | 27 | 0.76 | Why? |
| Pregnancy Tests | 1 | 2018 | 17 | 0.75 | Why? |
| Thyrotoxicosis | 1 | 2019 | 59 | 0.73 | Why? |
| Osteolysis | 1 | 2018 | 57 | 0.70 | Why? |
| Coagulase | 1 | 2017 | 44 | 0.69 | Why? |
| Peptide Fragments | 2 | 2018 | 2075 | 0.68 | Why? |
| Osteogenesis | 1 | 2018 | 95 | 0.67 | Why? |
| Antibodies, Viral | 10 | 2021 | 51949 | 0.66 | Why? |
| Foot | 1 | 2018 | 195 | 0.64 | Why? |
| Medical Errors | 1 | 2019 | 201 | 0.60 | Why? |
| Osteomyelitis | 1 | 2017 | 131 | 0.59 | Why? |
| Germinal Center | 1 | 2018 | 332 | 0.58 | Why? |
| Staphylococcus aureus | 2 | 2018 | 844 | 0.56 | Why? |
| Prosthesis-Related Infections | 1 | 2018 | 302 | 0.53 | Why? |
| Obesity | 4 | 2018 | 7388 | 0.53 | Why? |
| Testosterone | 1 | 2019 | 596 | 0.50 | Why? |
| Diabetes Mellitus, Type 2 | 3 | 2018 | 6166 | 0.48 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.46 | Why? |
| Immunity, Humoral | 3 | 2021 | 4849 | 0.45 | Why? |
| Natriuretic Peptide, Brain | 1 | 2018 | 1215 | 0.43 | Why? |
| False Positive Reactions | 3 | 2020 | 1338 | 0.43 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.42 | Why? |
| Immunoassay | 3 | 2020 | 4485 | 0.42 | Why? |
| Laboratories | 2 | 2021 | 2858 | 0.39 | Why? |
| Whole Genome Sequencing | 1 | 2020 | 3239 | 0.39 | Why? |
| Heart Failure | 2 | 2019 | 6638 | 0.33 | Why? |
| Immunoglobulin M | 2 | 2020 | 9091 | 0.31 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.31 | Why? |
| Osteoarthritis | 2 | 2018 | 205 | 0.29 | Why? |
| Mice, Inbred C57BL | 5 | 2018 | 5542 | 0.28 | Why? |
| Point-of-Care Systems | 1 | 2018 | 2955 | 0.28 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.27 | Why? |
| B-Lymphocytes | 1 | 2018 | 4418 | 0.25 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.25 | Why? |
| Sensitivity and Specificity | 5 | 2021 | 22971 | 0.23 | Why? |
| HLA-DRB1 Chains | 1 | 2021 | 196 | 0.20 | Why? |
| Reagent Kits, Diagnostic | 2 | 2020 | 2149 | 0.20 | Why? |
| HLA-A Antigens | 1 | 2021 | 196 | 0.20 | Why? |
| Antibodies, Neutralizing | 3 | 2021 | 25288 | 0.20 | Why? |
| International Normalized Ratio | 1 | 2021 | 300 | 0.19 | Why? |
| ROC Curve | 2 | 2021 | 6024 | 0.18 | Why? |
| Aminoglycosides | 1 | 2018 | 94 | 0.18 | Why? |
| Clinical Chemistry Tests | 1 | 2019 | 82 | 0.18 | Why? |
| Seroepidemiologic Studies | 4 | 2021 | 10017 | 0.18 | Why? |
| Inflammation | 2 | 2018 | 13255 | 0.18 | Why? |
| Immunoglobulin Class Switching | 1 | 2018 | 133 | 0.18 | Why? |
| Cytidine Deaminase | 1 | 2018 | 109 | 0.18 | Why? |
| Collagen Type I | 1 | 2017 | 56 | 0.17 | Why? |
| Diet, High-Fat | 1 | 2018 | 161 | 0.17 | Why? |
| Cartilage, Articular | 1 | 2017 | 50 | 0.17 | Why? |
| Warfarin | 1 | 2021 | 402 | 0.16 | Why? |
| Transcriptional Activation | 1 | 2017 | 196 | 0.16 | Why? |
| Hemolysis | 1 | 2018 | 283 | 0.15 | Why? |
| Mice | 5 | 2018 | 21357 | 0.15 | Why? |
| Predictive Value of Tests | 2 | 2021 | 9537 | 0.15 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.15 | Why? |
| Disease Models, Animal | 3 | 2018 | 10998 | 0.14 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.14 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.14 | Why? |
| Abscess | 1 | 2017 | 234 | 0.14 | Why? |
| Humans | 25 | 2021 | 930598 | 0.14 | Why? |
| Coronavirus NL63, Human | 1 | 2020 | 669 | 0.14 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.13 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.13 | Why? |
| Antibodies, Bacterial | 1 | 2017 | 510 | 0.13 | Why? |
| New York | 1 | 2020 | 2488 | 0.12 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.12 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.12 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2018 | 676 | 0.11 | Why? |
| Creatinine | 1 | 2018 | 1443 | 0.11 | Why? |
| Male | 13 | 2021 | 367725 | 0.11 | Why? |
| False Negative Reactions | 1 | 2018 | 1785 | 0.11 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2018 | 830 | 0.11 | Why? |
| Fibrinogen | 1 | 2017 | 1048 | 0.11 | Why? |
| Blood Transfusion | 1 | 2020 | 1399 | 0.10 | Why? |
| Missouri | 2 | 2021 | 274 | 0.10 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.10 | Why? |
| Patient Care | 1 | 2021 | 1664 | 0.10 | Why? |
| Virulence | 1 | 2017 | 2172 | 0.10 | Why? |
| Up-Regulation | 1 | 2017 | 2249 | 0.09 | Why? |
| Macrophages | 2 | 2018 | 2784 | 0.09 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.09 | Why? |
| Academic Medical Centers | 1 | 2020 | 3088 | 0.09 | Why? |
| Sequence Analysis, RNA | 1 | 2017 | 2290 | 0.09 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.08 | Why? |
| Monitoring, Physiologic | 1 | 2018 | 1956 | 0.08 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.08 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.08 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.08 | Why? |
| Animals | 5 | 2018 | 78931 | 0.08 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.07 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.07 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.07 | Why? |
| Dietary Supplements | 1 | 2017 | 2251 | 0.07 | Why? |
| Electrocardiography | 1 | 2019 | 3957 | 0.07 | Why? |
| Diagnosis, Differential | 1 | 2019 | 7220 | 0.07 | Why? |
| Wounds and Injuries | 1 | 2017 | 1708 | 0.07 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.06 | Why? |
| Female | 7 | 2021 | 380317 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2021 | 4273 | 0.06 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.06 | Why? |
| Kidney Failure, Chronic | 1 | 2018 | 3222 | 0.06 | Why? |
| Aged | 4 | 2021 | 215776 | 0.05 | Why? |
| Adult | 5 | 2021 | 244371 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Anticoagulants | 1 | 2021 | 9563 | 0.05 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.05 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.05 | Why? |
| Bifidobacterium longum | 1 | 2018 | 23 | 0.05 | Why? |
| Oligosaccharides | 1 | 2018 | 69 | 0.04 | Why? |
| Haptoglobins | 1 | 2018 | 117 | 0.04 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.04 | Why? |
| Hydrolysis | 1 | 2017 | 160 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 9335 | 0.04 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.04 | Why? |
| Gene Frequency | 1 | 2021 | 1210 | 0.04 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.04 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.04 | Why? |
| Alleles | 1 | 2021 | 1557 | 0.04 | Why? |
| Hematologic Tests | 1 | 2018 | 521 | 0.03 | Why? |
| Polymorphism, Genetic | 1 | 2021 | 1074 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.03 | Why? |
| Hemoglobins | 1 | 2018 | 958 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Dysbiosis | 1 | 2018 | 685 | 0.03 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.03 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.03 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Fatal Outcome | 1 | 2018 | 3438 | 0.02 | Why? |
| Outpatients | 1 | 2021 | 3417 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Child | 3 | 2021 | 70012 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2021 | 4027 | 0.02 | Why? |
| Transcriptome | 1 | 2018 | 3466 | 0.02 | Why? |
| Palliative Care | 1 | 2018 | 2665 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
Farnsworth's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(142)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(78)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_